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Abstract
The uses and misuses of the Journal Impact Factor (JIF) have been thoroughly discussed in the literature. A few
years ago, I predicted that JIF would soon be replaced, while another colleague argued the opposite. Over the past
few months, attacks on JIF have intensified, with some publishing organizations gradually removing the indicator
from their journals’ websites. Here, I argue that most, if not all of the misuses of JIF are related to its name. The
word “impact” should be removed, since it implies an influential attribute, either for the journals, their published
papers, or their authors. I propose instead the use of a new name, the “CAPCI factor”, standing for Citation Average
Per Citable Item, which accurately describes what is represented by this measure.
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Editorial
More than 50 years ago, information scientist Eugene
Garfield and colleagues described a simple publication
indicator, known as the Journal Impact Factor (JIF) [1].
The JIF indicates the average number of citations
received by papers published in a specific journal over a
specific period of time. The calculation is very elemen-
tary math; divide the number of citations of all papers
published in a journal over a specific time period (say 1,
2, or 5 years) by the number of papers published and ….
Eureka! You have your number.
Like every other simple “discovery”, Garfield did not
anticipate that this calculation was destined to be-
come his greatest hit. This story is reminiscent of
numerous other unlikely “successes”, one example
being the polymerase chain reaction – a simple
molecular biology technique that went on to make
billions of dollars in commercial products and won a
Nobel prize. Yet, why has the JIF enjoyed so much
publicity in recent years? I believe that the JIF was
born at just the right time, when explosive growth and
revolutionary changes took place in academic publishing,
mainly related to the electronic and digital era. Authors,
publishers, funders, and other stakeholders were hungry
for a metric that could separate, with a glimpse of eye,
published gold from published mediocrity. But, is the JIF
really telling you this?
Now, please allow me to divert, to make an analogy
which has many similarities with the issue at hand.
Many know that my favorite sport is tennis. Let us ask
the question as to how many tennis balls, on average, a
player is consuming over a certain period, say a year or
two. Like the JIF, you can get your answer by dividing
the number of sold balls by the number of the customers
of a tennis shop. This is the Tennis Ball Impact Factor!
Let us now ask if one shop should be considered ‘better’
than another if it sells more tennis balls per customer. It
could indeed be that the better selling shop has better
service, but other explanations may be at play, such as
better advertising or a better location! Thus, selling more
balls per customer (thus having higher Tennis Ball
Impact Factor) may or may not be related to the quality
of the shop. Let us now examine some other issues, not
so much related to the shop but to its customers. Could
a customer who buys balls from the best-selling shop
claim that they could play better tennis than somebody
who buys balls from a less popular shop? If the answer is
yes (but unfortunately it isn’t), then I would rush to buy
balls from that shop, in hopes of improving my game!
Even better, I would buy balls from Roger Federer’s favor-
ite shop, in hopes that my chances to win Wimbledon will
skyrocket! I wish it were that simple!
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With these thoughts in mind, I came to the conclu-
sion, in 2009, that the JIF will not endure the test of
time and would soon be replaced [2]. I predicted that
Garfield’s simple calculation was not likely to become,
or remain, the widely sought top quality indicator in
scientific publishing, like Wimbledon is for tennis, the
Master’s for golf, or the Kentucky Derby for horse racing.
My colleague, Dr. E.J. Favaloro, had the opposite opinion.
Our debate on this issue has been published [2, 3].
Of course, I am not the first to criticize the JIF.
Numerous editors, authors, and Associations of Editors
expressed concerns with the use and misuse of JIF, and
these concerns will not be repeated here [4–6]. I briefly
summarize that the consensus is that the JIF should not
be used as a surrogate measure of quality of individual
research papers or for assessing an author’s scientific
contribution, nor used to hire, promote, or fund
individuals [7].
The JIF debate is closely monitored by authors, edi-
tors, and publishers. Some leading journals, including
Nature and Science, are trying to devise improved indi-
cators of journal performance [8, 9]. For example, it is
well-known that the distributions of citations among
published papers are highly skewed to the right (see data
in [9]) and the use of mean citation values leads to the
estimation of a much higher JIF than by using the me-
dians instead. For example, Nature’s JIF went from 38
(with means) to 24 (with medians). It is rather appalling
that this simple, and seemingly better, calculation has
not already been widely implemented. After all, we teach
our undergraduates never to use parametric tests (in-
cluding means) if the data distributions are not normal!
Yet, the reason may be obvious – I would not imagine
any editor or publishing executive who would adopt an
improved measure of the JIF if it implies that their
current JIF would go down! The reverse is likely also
true, wherein nearly all editors would immediately adopt
a revision of the current calculation if it were to improve
their JIF. Nature, and some other elite journals, are a
special case. Since they rein in scientific publishing
prestige, the JIF is of no consequence to them. Authors
would still prefer them from any other journal with a
much higher JIF.
Change the name of the JIF
Herein, I present an amusing suggestion to modify the
JIF calculation in a way which, I suspect, would be highly
popular. Let us calculate the JIF as usual, but include a
per capita correction (i.e., per million) for the country
that the journal is published in. Assume the current JIF
of a journal published in the USA to be 20. Correcting
per million, the new JIF would be 20/360 = 0.06. How-
ever, if published in Monaco (0.04 million inhabitants),
the JIF would be 20/0.04 = 500. Based on this, I would
predict that most, if not all, journals published in the
USA will move their editorial offices to Monaco within
1 year, even if the newly elected US President would
likely oppose it!
The voices against JIF are now becoming louder [7–10].
The American Society for Microbiology has already
announced plans to remove the JIF from their journal’s
website as well as from their marketing and advertising
efforts. In 2013, I predicted that the role of journals will
change, even more, to become repositories of information
to be continuously assessed by readers [5]. If this happens,
the JIF will become an irrelevant measure.
In closing, I believe that many of the problems associ-
ated with JIF are related to its name. Surprisingly, this
issue has not been frequently discussed in previous
debates. The word “impact” implies that this number
carries influential information of some sort, either for
the journal (somewhat legitimate) or for the authors (to-
tally illegitimate). I am thus proposing that the current
name is replaced by the term CAPCI factor, or Citation
Average Per Citable Item, which accurately depicts what
the factor represents. While I have very frequently seen
claims such as “my work has high impact since it is
published in a high impact journal”, I highly doubt that
any sensible scientist would claim that “my work has
high impact because it is published in a journal with
high CAPCI factor”.
So, where would you buy your tennis balls? I would
advise finding a shop that sells more balls, not so much
that this will help your game, or that the balls will be
better, but because you will likely get a lower price!
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